February 20, 2018 / 7:16 PM / 4 months ago

BRIEF-Oramed Pharmaceuticals' Unit Enters Clinical Research Organization Services Agreement With Integrium

Feb 20 (Reuters) - Oramed Pharmaceuticals Inc:

* SAYS ON FEB 14, A UNIT ENTERED CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT WITH INTEGRIUM EFFECTIVE AS OF NOV 1, 2017‍​

* SAYS ‍AGREEMENT TO RETAIN INTEGRIUM AS CLINICAL RESEARCH ORGANIZATION FOR UNIT'S PLANNED UPCOMING 3-MONTH DOSE-RANGING CLINICAL TRIAL​ - SEC FILING

* SAYS ‍AS CONSIDERATION FOR SERVICES, UNIT TO PAY INTEGRIUM UP TO $7 MILLION TO BE PAID OVER TERM OF ENGAGEMENT, BASED ON ACHIEVEMENT OF SOME MILESTONES​ Source text: (bit.ly/2ETuakT) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below